Paul Riley: Is Thrombin Generation Assay Ready for Prime Time?
Paul Riley, Scientific Marketing Manager at Diagnostica Stago, shared on LinkedIn about his recent article, adding:
”Happy to share a new review article on thrombin generation testing I wrote and recently accepted by Clinics in Laboratory Medicine for a special edition.
The article describes a assay I am very passionate about which has the potential to give clinicians better information about patients’ global risk of bleeding or thrombosis.
The assay is not FDA cleared but available for research in the US and Canada.
It is being used in clinical settings internationally, though in limited volume.
Hopefully usage will increase over time especially if there’s a successful FDA submission at some point.
Thank you to the editors for inviting me to contribute.”
Title: Thrombin Generation Assay: Ready for Prime Time
Authors: Paul Riley
Read the Full Article on Clinics in Laboratory Medicine
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 25, 2026, 17:10Abdul Mannan: 10-Minute FVIII Inhibitor Screening Test
-
Apr 25, 2026, 16:55Connie Montgomery: Highlights from the Hemophilia Federation of America Symposium 2026
-
Apr 25, 2026, 16:35Fernanda Aspilche: Bringing the Alpha-1 Community to the European Parliament
-
Apr 25, 2026, 15:49Brian O Mahony: Expanding the Non-Replacement Therapy Toolbox
-
Apr 25, 2026, 15:44Toong Youttananukorn: Six Abstracts Demonstrate the Impact of WBDR at WFH Congress 2026
-
Apr 25, 2026, 15:08Lakmali Silva: Just Back from a Truly Energising Days in the UNC 12th Symposium on Hemostasis
-
Apr 25, 2026, 15:08Peripheral Blood Smear (PBS) Under the Microscope: Bridging Morphology and Hematology
-
Apr 25, 2026, 15:06Pushpendra Dwivedi: Blood Availability as One of Those Silent Problems No One Notices, Until It’s Too Late
-
Apr 25, 2026, 15:05Faheema Hasan: Chronic Methemoglobinemia Causing Longstanding Tissue Hypoxia and Secondary Erythrocytosis